Involvement of CD8+ T cells in multiple sclerosis

Frontiers in Immunology

Volumn 6, Issue NOV, 2015, Pages

  Salou, Marion ^a,b   Nicol, Bryan ^a,b   Garcia, Alexandra ^a,c   Laplaud, David Axel ^a,c  

^a INSERM   (France)

^b UNIVERSITÉ DE NANTES   (France)

^c Nantes Hospital   (France)

Author keywords

Autoimmunity; CD8+ T cells; Multiple sclerosis

Indexed keywords

INTERLEUKIN 17;

AUTOIMMUNITY; CD8+ T LYMPHOCYTE; CELL FUNCTION; CELL MIGRATION; CENTRAL NERVOUS SYSTEM FUNCTION; CEREBROSPINAL FLUID CYTOLOGY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOLOGY; INFLAMMATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MULTIPLE SCLEROSIS; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; REVIEW; RISK FACTOR; T LYMPHOCYTE ACTIVATION;

EID: 84949570359     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2015.00604     Document Type: Review

References (98)

1. Compston A, Coles A. Multiple sclerosis. Lancet (2008) 372:1502-17. doi:10.1016/S0140-6736(08)61620-7.
2. Pierrot-Deseilligny C, Souberbielle J-C. Is hypovitaminosis D one of the environmental risk factors for multiple sclerosis? Brain (2010) 133:1869-88. doi:10.1093/brain/awq147.
3. Sospedra M, Martin R. Immunology of multiple sclerosis. Annu Rev Immunol (2005) 23:683-747. doi:10.1146/annurev.immunol.23.021704.115707.
4. Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG. Multiple sclerosis. N Engl J Med (2000) 343:938-52. doi:10.1056/NEJM200009283431307.
5. Van Oosten BW, Lai M, Hodgkinson S, Barkhof F, Miller DH, Moseley IF, et al. Treatment of multiple sclerosis with the monoclonal anti-CD4 antibody cM-T412: results of a randomized, double-blind, placebo-controlled, MR-monitored phase II trial. Neurology (1997) 49:351-7. doi:10.1212/WNL.49.2.351.
6. Sinha S, Itani FR, Karandikar NJ. Immune regulation of multiple sclerosis by CD8+ T cells. Immunol Res (2014) 59:254-65. doi:10.1007/s12026-014-8529-9.
7. Denic A, Wootla B, Rodriguez M. CD8(+) T cells in multiple sclerosis. Expert Opin Ther Targets (2013) 17:1053-66. doi:10.1517/14728222.2013.815726.
8. Brown MA, Rubio JP, Bahlo M, Stankovich J, Danoy P, Hickey PF, et al. Saliva-derived DNA performs well in large-scale, high-density single-nucleotide polymorphism microarray studies. Cancer Epidemiol Biomarkers Prev (2010) 19:794-8. doi:10.1158/1055-9965.EPI-09-0812.
9. Baranzini SE, Wang J, Gibson RA, Galwey N, Naegelin Y, Barkhof F, et al. Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. Hum Mol Genet (2009) 18:767-78. doi:10.1093/hmg/ddn388.
10. Sawcer S, Hellenthal G, Pirinen M, Spencer CCA, Patsopoulos NA, Moutsianas L, et al. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature (2011) 476:214-9. doi:10.1038/nature10251.
11. Hafler DA, Compston A, Sawcer S, Lander ES, Daly MJ, De Jager PL, et al. Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med (2007) 357:851-62. doi:10.1056/NEJMoa073493.
12. Esposito F, Reischl J, Lehr S, Bauer D, Heubach J, Sandbrink R, et al. Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci. Ann Neurol (2011) 70:897-912. doi:10.1002/ana.22609.
13. Sawcer S, Franklin RJM, Ban M. Multiple sclerosis genetics. Lancet Neurol (2014) 13:700-9. doi:10.1016/S1474-4422(14)70041-9.
14. Jersild C, Svejgaard A, Fog T. HL-A antigens and multiple sclerosis. Lancet (1972) 1:1240-1. doi:10.1016/S0140-6736(72)90962-2.
15. Naito S, Namerow N, Mickey MR, Terasaki PI. Multiple sclerosis: association with HL-A3. Tissue Antigens (1972) 2:1-4. doi:10.1111/j.1399-0039.1972.tb00111.x.
16. Fogdell-Hahn A, Ligers A, Grønning M, Hillert J, Olerup O. Multiple sclerosis: a modifying influence of HLA class I genes in an HLA class II associated autoimmune disease. Tissue Antigens (2000) 55:140-8. doi:10.1034/j.1399-0039.2000.550205.x.
17. Harbo HF, Lie BA, Sawcer S, Celius EG, Dai K-Z, Oturai A, et al. Genes in the HLA class I region may contribute to the HLA class II-associated genetic susceptibility to multiple sclerosis. Tissue Antigens (2004) 63:237-47. doi:10.1111/j.0001-2815.2004.00173.x.
18. Friese MA, Jakobsen KB, Friis L, Etzensperger R, Craner MJ, McMahon RM, et al. Opposing effects of HLA class I molecules in tuning autoreactive CD8+ T cells in multiple sclerosis. Nat Med (2008) 14:1227-35. doi:10.1038/nm.1881.
19. Booss J, Esiri MM, Tourtellotte WW, Mason DY. Immunohistological analysis of T lymphocyte subsets in the central nervous system in chronic progressive multiple sclerosis. J Neurol Sci (1983) 62:219-32. doi:10.1016/0022-510X(83)90201-0.
20. Hauser SL, Bhan AK, Gilles F, Kemp M, Kerr C, Weiner HL. Immunohistochemical analysis of the cellular infiltrate in multiple sclerosis lesions. Ann Neurol (1986) 19:578-87. doi:10.1002/ana.410190610.
21. Salou M, Garcia A, Michel L, Gainche-Salmon A, Loussouarn D, Nicol B, et al. Expanded CD8 T-cell sharing between periphery and CNS in multiple sclerosis. Ann Clin Transl Neurol (2015) 2:609-22. doi:10.1002/acn3.199.
22. Babbe H, Roers A, Waisman A, Lassmann H, Goebels N, Hohlfeld R, et al. Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction. J Exp Med (2000) 192:393-404. doi:10.1084/jem.192.3.393.
23. Junker A, Ivanidze J, Malotka J, Eiglmeier I, Lassmann H, Wekerle H, et al. Multiple sclerosis: T-cell receptor expression in distinct brain regions. Brain (2007) 130:2789-99. doi:10.1093/brain/awm214.
24. Skulina C, Schmidt S, Dornmair K, Babbe H, Roers A, Rajewsky K, et al. Multiple sclerosis: brain-infiltrating CD8+ T cells persist as clonal expansions in the cerebrospinal fluid and blood. Proc Natl Acad Sci U S A (2004) 101:2428-33. doi:10.1073/pnas.0308689100.
25. Ifergan I, Kebir H, Alvarez JI, Marceau G, Bernard M, Bourbonnière L, et al. Central nervous system recruitment of effector memory CD8+ T lymphocytes during neuroinflammation is dependent on a4 integrin. Brain (2011) 134:3557-74. doi:10.1093/brain/awr268.
26. Tzartos JS, Friese MA, Craner MJ, Palace J, Newcombe J, Esiri MM, et al. Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis. Am J Pathol (2008) 172:146-55. doi:10.2353/ajpath.2008.070690.
27. Lucchinetti CF, Popescu BFG, Bunyan RF, Moll NM, Roemer SF, Lassmann H, et al. Inflammatory cortical demyelination in early multiple sclerosis. N Engl J Med (2011) 365:2188-97. doi:10.1056/NEJMoa1100648.
28. Höftberger R, Aboul-Enein F, Brueck W, Lucchinetti C, Rodriguez M, Schmidbauer M, et al. Expression of major histocompatibility complex class I molecules on the different cell types in multiple sclerosis lesions. Brain Pathol (2004) 14:43-50. doi:10.1111/j.1750-3639.2004.tb00496.x.
29. Medana I, Martinic MA, Wekerle H, Neumann H. Transection of major histocompatibility complex class I-induced neurites by cytotoxic T lymphocytes. Am J Pathol (2001) 159:809-15. doi:10.1016/S0002-9440(10)61755-5.
30. Trapp BD, Peterson J, RansohoffRM, Rudick R, Mörk S, Bö L. Axonal transection in the lesions of multiple sclerosis. N Engl J Med (1998) 338:278-85. doi:10.1056/NEJM199801293380502.
31. Bitsch A, Schuchardt J, Bunkowski S, Kuhlmann T, Brück W. Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation. Brain (2000) 123(Pt 6):1174-83. doi:10.1093/brain/123.6.1174.
32. Annibali V, Ristori G, Angelini DF, Serafini B, Mechelli R, Cannoni S, et al. CD161(high)CD8+T cells bear pathogenetic potential in multiple sclerosis. Brain (2011) 134:542-54. doi:10.1093/brain/awq354.
33. Jilek S, Schluep M, Rossetti AO, Guignard L, Le GoffG, Pantaleo G, et al. CSF enrichment of highly differentiated CD8+ T cells in early multiple sclerosis. Clin Immunol (2007) 123:105-13. doi:10.1016/j.clim.2006.11.004.
34. Malmeström C, Lycke J, Haghighi S, Andersen O, Carlsson L, Wadenvik H, et al. Relapses in multiple sclerosis are associated with increased CD8+ T-cell mediated cytotoxicity in CSF. J Neuroimmunol (2008) 196:159-65. doi:10.1016/j.jneuroim.2008.03.001.
35. Larochelle C, Lécuyer M-A, Alvarez JI, Charabati M, Saint-Laurent O, Ghannam S, et al. Melanoma cell adhesion molecule-positive CD8 T lymphocytes mediate central nervous system inflammation. Ann Neurol (2015) 78:39-53. doi:10.1002/ana.24415.
36. Larochelle C, Cayrol R, Kebir H, Alvarez JI, Lécuyer M-A, Ifergan I, et al. Melanoma cell adhesion molecule identifies encephalitogenic T lymphocytes and promotes their recruitment to the central nervous system. Brain (2012) 135:2906-24. doi:10.1093/brain/aws212.
37. Flanagan K, Fitzgerald K, Baker J, Regnstrom K, Gardai S, Bard F, et al. Laminin-411 is a vascular ligand for MCAM and facilitates TH17 cell entry into the CNS. PLoS One (2012) 7:e40443. doi:10.1371/journal.pone.0040443.
38. Duan H, Xing S, Luo Y, Feng L, Gramaglia I, Zhang Y, et al. Targeting endothelial CD146 attenuates neuroinflammation by limiting lymphocyte extravasation to the CNS. Sci Rep (2013) 3:1687. doi:10.1038/srep01687.
39. Juliano RL, Ling V. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta (1976) 455:152-62. doi:10.1016/0005-2736(76)90160-7.
40. Kooij G, Backer R, Koning JJ, Reijerkerk A, van Horssen J, van der Pol SMA, et al. P-glycoprotein acts as an immunomodulator during neuroinflammation. PLoS One (2009) 4:e8212. doi:10.1371/journal.pone.0008212.
41. Kooij G, Kroon J, Paul D, Reijerkerk A, Geerts D, van der Pol SMA, et al. P-glycoprotein regulates trafficking of CD8(+) T cells to the brain parenchyma. Acta Neuropathol (2014) 127:699-711. doi:10.1007/s00401-014-1244-8.
42. Elong Ngono A, Pettré S, Salou M, Bahbouhi B, Soulillou J-P, Brouard S, et al. Frequency of circulating autoreactive T cells committed to myelin determinants in relapsing-remitting multiple sclerosis patients. Clin Immunol (2012) 144:117-26. doi:10.1016/j.clim.2012.05.009.
43. Sewell AK. Why must T cells be cross-reactive? Nat Rev Immunol (2012) 12:669-77. doi:10.1038/nri3279.
44. Zhang X, Tang Y, Sujkowska D, Wang J, Ramgolam V, Sospedra M, et al. Degenerate TCR recognition and dual DR2 restriction of autoreactive T cells: implications for the initiation of the autoimmune response in multiple sclerosis. Eur J Immunol (2008) 38:1297-309. doi:10.1002/eji.200737519.
45. Ji Q, Perchellet A, Goverman JM. Viral infection triggers central nervous system autoimmunity via activation of CD8+ T cells expressing dual TCRs. Nat Immunol (2010) 11:628-34. doi:10.1038/ni.1888.
46. Kim S-M, Bhonsle L, Besgen P, Nickel J, Backes A, Held K, et al. Analysis of the paired TCR a-and β-chains of single human T cells. PLoS One (2012) 7:e37338. doi:10.1371/journal.pone.0037338.
47. Goebels N, Hofstetter H, Schmidt S, Brunner C, Wekerle H, Hohlfeld R. Repertoire dynamics of autoreactive T cells in multiple sclerosis patients and healthy subjects: epitope spreading versus clonal persistence. Brain (2000) 123(Pt 3):508-18. doi:10.1093/brain/123.3.508.
48. Croxford JL, Olson JK, Miller SD. Epitope spreading and molecular mimicry as triggers of autoimmunity in the Theiler's virus-induced demyelinating disease model of multiple sclerosis. Autoimmun Rev (2002) 1:251-60. doi:10.1016/S1568-9972(02)00080-0.
49. Gran B, Gestri D, Sottini A, Quiròs Roldàn E, Bettinardi A, Signorini S, et al. Detection of skewed T-cell receptor V-beta gene usage in the peripheral blood of patients with multiple sclerosis. J Neuroimmunol (1998) 85:22-32. doi:10.1016/S0165-5728(97)00250-6.
50. Laplaud D-A, Ruiz C, Wiertlewski S, Brouard S, Berthelot L, Guillet M, et al. Blood T-cell receptor beta chain transcriptome in multiple sclerosis. Characterization of the T cells with altered CDR3 length distribution. Brain (2004) 127:981-95. doi:10.1093/brain/awh119.
51. Matsumoto Y, Yoon WK, Jee Y, Fujihara K, Misu T, Sato S, et al. Complementarity-determining region 3 spectratyping analysis of the TCR repertoire in multiple sclerosis. J Immunol (2003) 170:4846-53. doi:10.4049/jimmunol.170.9.4846.
52. Monteiro J, Hingorani R, Peroglizzi R, ApatoffB, Gregersen PK. Oligoclonality of CD8+ T cells in multiple sclerosis. Autoimmunity (1996) 23:127-38. doi:10.3109/08916939608995336.
53. Muraro PA, Bonanni L, Mazzanti B, Pantalone A, Traggiai E, Massacesi L, et al. Short-term dynamics of circulating T cell receptor V beta repertoire in relapsing-remitting MS. J Neuroimmunol (2002) 127:149-59. doi:10.1016/S0165-5728(02)00105-4.
54. Démoulins T, Mouthon F, Clayette P, Bequet D, Gachelin G, Dormont D. The same TCR (N)Dbeta(N)Jbeta junctional region is associated with several different vbeta13 subtypes in a multiple sclerosis patient at the onset of the disease. Neurobiol Dis (2003) 14:470-82. doi:10.1016/j.nbd.2003.07.001.
55. Jacobsen M, Cepok S, Quak E, Happel M, Gaber R, Ziegler A, et al. Oligoclonal expansion of memory CD8+ T cells in cerebrospinal fluid from multiple sclerosis patients. Brain (2002) 125:538-50. doi:10.1093/brain/awf059.
56. Lozeron P, Chabas D, Duprey B, Lyon-Caen O, Liblau R. T cell receptor V beta 5 and V beta 17 clonal diversity in cerebrospinal fluid and peripheral blood lymphocytes of multiple sclerosis patients. Mult Scler (1998) 4:154-61. doi:10.1177/135245859800400313.
57. Laplaud D-A, Berthelot L, Miqueu P, Bourcier K, Moynard J, Oudinet Y, et al. Serial blood T cell repertoire alterations in multiple sclerosis patients; correlation with clinical and MRI parameters. J Neuroimmunol (2006) 177:151-60. doi:10.1016/j.jneuroim.2006.05.006.
58. Muraro PA, Cassiani-Ingoni R, Chung K, Packer AN, Sospedra M, Martin R. Clonotypic analysis of cerebrospinal fluid T cells during disease exacerbation and remission in a patient with multiple sclerosis. J Neuroimmunol (2006) 171:177-83. doi:10.1016/j.jneuroim.2005.10.002.
59. Crawford MP, Yan SX, Ortega SB, Mehta RS, Hewitt RE, Price DA, et al. High prevalence of autoreactive, neuroantigen-specific CD8+ T cells in multiple sclerosis revealed by novel flow cytometric assay. Blood (2004) 103:4222-31. doi:10.1182/blood-2003-11-4025.
60. Lolli F, Martini H, Citro A, Franceschini D, Portaccio E, Amato MP, et al. Increased CD8+ T cell responses to apoptotic T cell-associated antigens in multiple sclerosis. J Neuroinflammation (2013) 10:94. doi:10.1186/1742-2094-10-94.
61. Zang YCQ, Li S, Rivera VM, Hong J, Robinson RR, Breitbach WT, et al. Increased CD8+ cytotoxic T cell responses to myelin basic protein in multiple sclerosis. J Immunol (2004) 172:5120-7. doi:10.4049/jimmunol.172.8.5120.
62. Lossius A, Johansen JN, Vartdal F, Robins H, Jurate Šaltyte B, Holmøy T, et al. High-throughput sequencing of TCR repertoires in multiple sclerosis reveals intrathecal enrichment of EBV-reactive CD8+ T cells. Eur J Immunol (2014) 44:3439-52. doi:10.1002/eji.201444662.
63. Sun D, Whitaker JN, Huang Z, Liu D, Coleclough C, Wekerle H, et al. Myelin antigen-specific CD8+ T cells are encephalitogenic and produce severe disease in C57BL/6 mice. J Immunol (2001) 166:7579-87. doi:10.4049/jimmunol.166.12.7579.
64. Ford ML, Evavold BD. Specificity, magnitude, and kinetics of MOG-specific CD8+ T cell responses during experimental autoimmune encephalomyelitis. Eur J Immunol (2005) 35:76-85. doi:10.1002/eji.200425660.
65. Huseby ES, Liggitt D, Brabb T, Schnabel B, Ohlén C, Goverman J. A pathogenic role for myelin-specific CD8(+) T cells in a model for multiple sclerosis. J Exp Med (2001) 194:669-76. doi:10.1084/jem.194.5.669.
66. Lassmann H. Experimental models of multiple sclerosis. Rev Neurol (2007) 163:651-5. doi:10.1016/S0035-3787(07)90474-9.
67. Saxena A, Bauer J, Scheikl T, Zappulla J, Audebert M, Desbois S, et al. Cutting edge: multiple sclerosis-like lesions induced by effector CD8 T cells recognizing a sequestered antigen on oligodendrocytes. J Immunol (2008) 181:1617-21. doi:10.4049/jimmunol.181.3.1617.
68. Na S-Y, Cao Y, Toben C, Nitschke L, Stadelmann C, Gold R, et al. Naive CD8 T-cells initiate spontaneous autoimmunity to a sequestered model antigen of the central nervous system. Brain (2008) 131:2353-65. doi:10.1093/brain/awn148.
69. Na S-Y, Eujen H, Göbel K, Meuth SG, Martens K, Wiendl H, et al. Antigen-specific blockade of lethal CD8 T-cell mediated autoimmunity in a mouse model of multiple sclerosis. J Immunol (2009) 182:6569-75. doi:10.4049/jimmunol.0804200.
70. Johnson HL, Willenbring RC, Jin F, Manhart WA, LaFrance SJ, Pirko I, et al. Perforin competent CD8 T cells are sufficient to cause immune-mediated blood-brain barrier disruption. PLoS One (2014) 9:e111401. doi:10.1371/journal.pone.0111401.
71. Galea I, Bernardes-Silva M, Forse PA, van Rooijen N, Liblau RS, Perry VH. An antigen-specific pathway for CD8 T cells across the blood-brain barrier. J Exp Med (2007) 204:2023-30. doi:10.1084/jem.20070064.
72. Sobottka B, Harrer MD, Ziegler U, Fischer K, Wiendl H, Hünig T, et al. Collateral bystander damage by myelin-directed CD8+ T cells causes axonal loss. Am J Pathol (2009) 175:1160-6. doi:10.2353/ajpath.2009.090340.
73. Mars LT, Bauer J, Gross DA, Bucciarelli F, Firat H, Hudrisier D, et al. CD8 T cell responses to myelin oligodendrocyte glycoprotein-derived peptides in humanized HLA-A*0201-transgenic mice. J Immunol (2007) 179:5090-8. doi:10.4049/jimmunol.179.8.5090.
74. Wang HH, Dai YQ, Qiu W, Lu ZQ, Peng FH, Wang YG, et al. Interleukin-17-secreting T cells in neuromyelitis optica and multiple sclerosis during relapse. J Clin Neurosci (2011) 18:1313-7. doi:10.1016/j.jocn.2011.01.031.
75. Huber M, Heink S, Pagenstecher A, Reinhard K, Ritter J, Visekruna A, et al. IL-17A secretion by CD8+ T cells supports Th17-mediated autoimmune encephalomyelitis. J Clin Invest (2013) 123:247-60. doi:10.1172/JCI63681.
76. Billerbeck E, Kang Y-H, Walker L, Lockstone H, Grafmueller S, Fleming V, et al. Analysis of CD161 expression on human CD8+ T cells defines a distinct functional subset with tissue-homing properties. Proc Natl Acad Sci U S A (2010) 107:3006-11. doi:10.1073/pnas.0914839107.
77. Martin E, Treiner E, Duban L, Guerri L, Laude H, Toly C, et al. Stepwise development of MAIT cells in mouse and human. PLoS Biol (2009) 7:e1000054. doi:10.1371/journal.pbio.1000054.
78. Walker LJ, Kang Y-H, Smith MO, Tharmalingham H, Ramamurthy N, Fleming VM, et al. Human MAIT and CD8 cells develop from a pool of type-17 precommitted CD8+ T cells. Blood (2012) 119:422-33. doi:10.1182/blood-2011-05-353789.
79. Dusseaux M, Martin E, Serriari N, Peguillet I, Premel V, Louis D, et al. Human MAIT cells are xenobiotic-resistant, tissue-targeted, CD161hi IL-17-secreting T cells. Blood (2010) 117:1250-9. doi:10.1182/blood-2010-08-303339.
80. Patel O, Kjer-Nielsen L, Le Nours J, Eckle SBG, Birkinshaw R, Beddoe T, et al. Recognition of vitamin B metabolites by mucosal-associated invariant T cells. Nat Commun (2013) 4:2142. doi:10.1038/ncomms3142.
81. Reantragoon R, Corbett AJ, Sakala IG, Gherardin NA, Furness JB, Chen Z, et al. Antigen-loaded MR1 tetramers define T cell receptor heterogeneity in mucosal-associated invariant T cells. J Exp Med (2013) 210:2305-20. doi:10.1084/jem.20130958.
82. Treiner E, Duban L, Bahram S, Radosavljevic M, Wanner V, Tilloy F, et al. Selection of evolutionarily conserved mucosal-associated invariant T cells by MR1. Nature (2003) 422:164-9. doi:10.1038/nature01433.
83. Chua W-J, Kim S, Myers N, Huang S, Yu L, Fremont DH, et al. Endogenous MHC-related protein 1 is transiently expressed on the plasma membrane in a conformation that activates mucosal-associated invariant T cells. J Immunol (2011) 186:4744-50. doi:10.4049/jimmunol.1003254.
84. Le Bourhis L, Martin E, Péguillet I, Guihot A, Froux N, Coré M, et al. Antimicrobial activity of mucosal-associated invariant T cells. Nat Immunol (2010) 11:701-8. doi:10.1038/ni.1890.
85. Gold MC, Cerri S, Smyk-Pearson S, Cansler ME, Vogt TM, Delepine J, et al. Human mucosal associated invariant T cells detect bacterially infected cells. PLoS Biol (2010) 8:e1000407. doi:10.1371/journal.pbio.1000407.
86. Meierovics A, Yankelevich W-JC, Cowley SC. MAIT cells are critical for optimal mucosal immune responses during in vivo pulmonary bacterial infection. Proc Natl Acad Sci U S A (2013) 110:E3119-28. doi:10.1073/pnas.1302799110.
87. Teunissen MBM, Yeremenko NG, Baeten DLP, Chielie S, Spuls PI, de Rie MA, et al. The IL-17A-producing CD8+ T-cell population in psoriatic lesional skin comprises mucosa-associated invariant T cells and conventional T cells. J Invest Dermatol (2014) 134:2898-907. doi:10.1038/jid.2014.261.
88. Serriari N-E, Eoche M, Lamotte L, Lion J, Fumery M, Marcelo P, et al. Innate mucosal-associated invariant T (MAIT) cells are activated in inflammatory bowel diseases: MAIT cells in IBD. Clin Exp Immunol (2014) 176:266-74. doi:10.1111/cei.12277.
89. Dunne MR, Elliott L, Hussey S, Mahmud N, Kelly J, Doherty DG, et al. Persistent changes in circulating and intestinal γδ T cell subsets, invariant natural killer T cells and mucosal-associated invariant T cells in children and adults with coeliac disease. PLoS One (2013) 8:e76008. doi:10.1371/journal.pone.0076008.
90. Eidson M, Wahlstrom J, Beaulieu AM, Zaidi B, Carsons SE, Crow PK, et al. Altered development of NKT cells, γδ T cells, CD8 T cells and NK cells in a PLZF deficient patient. PLoS One (2011) 6:e24441. doi:10.1371/journal.pone.0024441.
91. Miyazaki Y, Miyake S, Chiba A, Lantz O, Yamamura T. Mucosal-associated invariant T cells regulate Th1 response in multiple sclerosis. Int Immunol (2011) 23:529-35. doi:10.1093/intimm/dxr047.
92. Abrahamsson SV, Angelini DF, Dubinsky AN, Morel E, Oh U, Jones JL, et al. Non-myeloablative autologous haematopoietic stem cell transplantation expands regulatory cells and depletes IL-17 producing mucosal-associated invariant T cells in multiple sclerosis. Brain (2013) 136:2888-903. doi:10.1093/brain/awt182.
93. Illes Z. Accumulation of V 7.2-J 33 invariant T cells in human autoimmune inflammatory lesions in the nervous system. Int Immunol (2004) 16:223-30. doi:10.1093/intimm/dxh018.
94. Held K, Bhonsle-Deeng L, Siewert K, Sato W, Beltrán E, Schmidt S, et al. aβ T-cell receptors from multiple sclerosis brain lesions show MAIT cell-related features. Neurol Neuroimmunol Neuroinflamm (2015) 2:e107. doi:10.1212/NXI.0000000000000107.
95. Willing A, Leach OA, Ufer F, Attfield KE, Steinbach K, Kursawe N, et al. CD8+ MAIT cells infiltrate into the CNS and alterations in their blood frequencies correlate with IL-18 serum levels in multiple sclerosis. Eur J Immunol (2014) 44:3119-28. doi:10.1002/eji.201344160.
96. Fergusson JR, Fleming VM, Klenerman P. CD161-expressing human T cells. Front Immunol (2011) 2:36. doi:10.3389/fimmu.2011.00036.
97. Dagur PK, Biancotto A, Stansky E, Sen HN, Nussenblatt RB, McCoy JP. Secretion of interleukin-17 by CD8+ T cells expressing CD146 (MCAM). Clin Immunol (2014) 152:36-47. doi:10.1016/j.clim.2014.01.009.
98. Ji Q, Castelli L, Goverman JM. MHC class I-restricted myelin epitopes are cross-presented by Tip-DCs that promote determinant spreading to CD8+ T cells. Nat Immunol (2013) 14:254-61. doi:10.1038/ni.2513.